INTERMEDIATE-DOSE INTRAVENOUS METHOTREXATE AND MERCAPTOPURINE THERAPY FOR NON-T, NON-B ACUTE LYMPHOCYTIC-LEUKEMIA OF CHILDHOOD - A PEDIATRIC-ONCOLOGY-GROUP STUDY

被引:108
|
作者
CAMITTA, B
LEVENTHAL, B
LAUER, S
SHUSTER, JJ
ADAIR, S
CASPER, J
CIVIN, C
GRAHAM, M
MAHONEY, D
MUNOZ, L
KIEFER, G
KAMEN, B
机构
[1] MED COLL WISCONSIN,DEPT PEDIAT,MIDWEST CHILDRENS CANC CTR,MILWAUKEE,WI 53226
[2] CHILDRENS HOSP WISCONSIN,MILWAUKEE,WI
[3] JOHNS HOPKINS UNIV HOSP,CTR ONCOL,BALTIMORE,MD 21205
[4] UNIV FLORIDA,PEDIAT ONCOL GRP,STAT OFF,GAINESVILLE,FL 32611
[5] WEBSTER CLIN,GREEN BAY,WI
[6] ST VINCENTS HOSP,GREEN BAY,WI
[7] BAYLOR UNIV,HOUSTON,TX 77030
[8] UNIV TEXAS,HLTH SCI CTR,SW MED SCH,DALLAS,TX 75235
关键词
D O I
10.1200/JCO.1989.7.10.1539
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1539 / 1544
页数:6
相关论文
共 50 条
  • [21] PROGNOSTIC-SIGNIFICANCE OF CD34 EXPRESSION IN CHILDHOOD B-PRECURSOR ACUTE LYMPHOCYTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP STUDY
    BOROWITZ, MJ
    SHUSTER, JJ
    CIVIN, CI
    CARROLL, AJ
    LOOK, AT
    BEHM, FG
    LAND, VJ
    PULLEN, DJ
    CRIST, WM
    JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (08) : 1389 - 1398
  • [22] EXTENDED TRIPLE INTRATHECAL CHEMOTHERAPY (TIC) IS HIGHLY EFFECTIVE AND SUPERIOR TO BRIEF TIC AND INTERMEDIATE-DOSE MTX (IDM) AS CNS PROPHYLAXIS IN NON-T, NON-B ALL - A PEDIATRIC ONCOLOGY GROUP (POG) STUDY
    CRIST, W
    BOYETT, J
    FRANKEL, L
    IYER, R
    VANEYS, J
    SULLIVAN, M
    HARRIS, M
    RAVINDRANATH, Y
    PULLEN, J
    MEDICAL AND PEDIATRIC ONCOLOGY, 1988, 16 (06): : 387 - 387
  • [23] MAYTANSINE IN REFRACTORY CHILDHOOD ACUTE LYMPHOCYTIC-LEUKEMIA - A PEDIATRIC ONCOLOGY GROUP-STUDY
    SABIO, H
    FRANKEL, L
    SEXAUER, C
    FALLETTA, J
    KIM, TH
    CANCER TREATMENT REPORTS, 1983, 67 (11): : 1045 - 1045
  • [24] SPECIES-SPECIFIC THERAPY OF NON-T NON-B ACUTE LYMPHOID LEUKEMIA (ALL)
    PINKEL, DP
    CULBERT, SJ
    LOCKHART, SK
    MULLINS, JK
    RAMIREZ, I
    ZIPF, TF
    PEDIATRIC RESEARCH, 1990, 27 (04) : A148 - A148
  • [25] Hematopoietic stem cell transplantation after first marrow relapse of non-T, non-B acute lymphoblastic leukemia - A Pediatric Oncology Group pilot feasibility study
    Sandler, Eric S.
    Homans, Alan
    Mandell, Lynda
    Amylon, Michael
    Wall, Donna A.
    Devidas, Meenakshi
    Buchanan, George R.
    Lipton, Jeffrey M.
    Billett, Amy L.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2006, 28 (04) : 210 - 215
  • [26] CHILDHOOD PRIMARY CUTANEOUS NON-T NON-B LYMPHOMA FOLLOWED BY ACUTE T-CELL LEUKEMIA
    TANG, TT
    LAUER, SJ
    HARB, JM
    KIRCHNER, PA
    ADAIR, SE
    CAMITTA, BM
    CANCER, 1986, 57 (12) : 2368 - 2374
  • [27] THE TREATMENT OF CHILDHOOD ACUTE LYMPHOCYTIC-LEUKEMIA WITH PROPHYLACTIC INTRATHECAL AND SYSTEMIC INTERMEDIATE-DOSE (150 MG/M2) METHOTREXATE
    MUCHI, H
    IJIMA, H
    SUDA, T
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1982, 12 (03) : 363 - 370
  • [28] THERAPY OF ACUTE LYMPHOCYTIC-LEUKEMIA IN CHILDHOOD WITH INTERMEDIATE DOSE METHOTREXATE AND CNS IRRADIATION - A REPORT OF THE ALL 77-02 STUDY-GROUP
    HAAS, RJ
    JANKA, G
    GAEDICKE, G
    KOHNE, E
    NETZEL, B
    BLUT, 1983, 47 (06): : 321 - 331
  • [29] REPETITIVE LOW-DOSE ORAL METHOTREXATE AND INTRAVENOUS MERCAPTOPURINE TREATMENT FOR PATIENTS WITH LOWER RISK B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP PILOT-STUDY
    MAHONEY, DH
    CAMITTA, BM
    LEVENTHAL, BG
    SHUSTER, JJ
    CIVIN, CJ
    GANICK, DJ
    LAUER, SJ
    STEUBER, CP
    KAMEN, BA
    CANCER, 1995, 75 (10) : 2623 - 2631
  • [30] A COMPARISON OF INDUCTION AND MAINTENANCE THERAPY FOR ACUTE NONLYMPHOCYTIC LEUKEMIA IN CHILDHOOD - RESULTS OF A PEDIATRIC-ONCOLOGY-GROUP STUDY
    STEUBER, CP
    CIVIN, C
    KRISCHER, J
    CULBERT, S
    RAGAB, A
    RUYMANN, FB
    RAVINDRANATH, Y
    LEVENTHAL, B
    WILKINSON, R
    VIETTI, TJ
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (02) : 247 - 258